Clinical trial
A Phase-II Trial of ZIO 101 in Advanced Hepatocellular Carcinoma
NCT00423306 · Alaunos Therapeutics, Industry · Unknown status
Key facts
| NCT number | NCT00423306 |
|---|---|
| Title | A Phase-II Trial of ZIO 101 in Advanced Hepatocellular Carcinoma |
| Official title | A Phase-II Trial of ZIO 101 in Advanced Hepatocellular Carcinoma |
| Lead sponsor | Alaunos Therapeutics, Industry |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HEPATOCELLULAR CARCINOMA |
| Intervention type | Drug |
| Interventions | Darinaparsin |
| Enrollment | 15 |
| Start date | Jan 1, 2007 |
| Primary completion | Dec 1, 2013 |
| Completion | Dec 1, 2013 |
| First posted | Jan 18, 2007 |
| Last update posted | Nov 14, 2013 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: